logo
Love butter? Here's what you should swap in to protect against heart disease and cancer

Love butter? Here's what you should swap in to protect against heart disease and cancer

Yahoo06-03-2025

Butter may be delicious, but a large new study suggests that the less of it you eat, the longer you may live.
Using more plant-based oils and less butter was associated with a 17% lower risk of dying prematurely and a lower risk of cancer and heart disease, according to a report published Thursday in JAMA Internal Medicine and presented at the American Heart Association EPI/Lifestyle Scientific Sessions.
Researchers at Brigham and Women's Hospital in Boston analyzed data from more than 200,000 people who were followed for more than three decades. Participants who reported consuming the highest daily amounts of butter were 15% more likely to die prematurely, while people who had a high intake of plant-based oils, especially soybean, canola and olive oil, were 16% less likely to die prematurely, the researchers found.
'The message from this study is: Less butter and more plant-based oil could lead to better health,' said the study's lead author, Yu Zhang, a graduate student at the Harvard T.H. Chan School of Public Health and a research assistant at Brigham and Women's Hospital.
'We're not saying that people should give up butter entirely,' Zhang said. 'But we're suggesting that a small reduction in the daily consumption of butter and an increase in plant-based oil could lead to significant long-term health benefits.'
Zhang couldn't say exactly how much butter would be OK to consume, but 'less would be better.'
The new study looked at data from 221,054 adults who had participated in the Nurses' Health Study, the Nurses' Health Study II and the Health Professionals Follow-up Study. At the outset, the average age of people in the Nurses' Health Study and Health Professionals Follow-up was 56; it was 36 in the Nurses' Health Study II.
Every four years, the participants filled out a food frequency questionnaire that included more than 130 items. They were asked how often, on average, they consumed each food item over the past year. The participants had nine possible responses ranging from 'never or less than once per month' to 'more than six or more times a day.'
They were also asked what types of fats and oils they consumed and what brands or types of oils they used.During the 33 years of follow-up, 50,932 of the participants died, 12,241 due to cancer and 11,240 due to heart disease.
After accounting for potentially biasing lifestyle factors, such as body mass index, amount of physical activity, smoking and alcohol consumption, as well as family history of diabetes, cancer and cardiovascular disease, the researchers determined that people who consumed the highest daily amount of butter (13 to 14 grams, or approximately three small pats) had a 15% greater chance of dying compared to those who consumed the lowest amount (0.1 to 0.2 grams, or almost none).
That's in contrast to a 16% lower risk of dying in those who consumed the highest amount of plant-based oils (around 25 grams, about five teaspoons a day) compared to those who consumed the least (around 3 grams per day, or 1 teaspoon).
Using a statistical model, the researchers estimated the difference in mortality rate when plant-based oils were substituted for about a teaspoon of butter each day and found a 17% lower risk of death.
When the researchers examined causes of death, they found that each additional 10 grams (roughly 2 teaspoons) per day of plant-based oil was associated with an 11% lower risk of death from cancer and a 6% lower risk of death from cardiovascular diseases.
Dr. Matthew Tomey, a cardiologist at the Mount Sinai Fuster Heart Hospital in New York City, said the new study is consistent with the current American Heart Association guidance regarding substituting polyunsaturated and unsaturated fats for animal and dairy fats.
'The large sample size and robust analysis provide insight, particularly with respect to substitution of plant-based oils for butter,' Tomey said.
The American Heart Association recommends getting less than 6% of total daily calories from saturated fat. For example, if someone is consuming 2,000 calories a day, no more than 120 calories of them should come from saturated fat. That's about 13 grams or less of saturated fat per day.
Does the new research mean butter should be off the menu?
Marie-Pierre St-Onge, an associate professor of nutritional medicine at the Columbia University Vagelos College of Physicians and Surgeons in New York City, said people should focus on the health benefits of plant-based oils.
'It shouldn't scare them from using butter,' she said, adding 'there's more benefit to plant-based oil than there is harm from butter.'
The only sign of harm from butter was in people who used it the most, she said.
It comes down to moderation. 'Practically speaking, having a pat of butter is not going to be the end of the world,' Tomey said.
It's OK to have a little butter, if you're careful about other animal or dairy fats, said Alice H. Lichtenstein, a professor of nutrition science and policy at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University.
'If you're not consuming a lot of meat and you're choosing low- or nonfat yogurt, then there's some room for butter,' Lichtenstein said. 'You shouldn't feel guilty about it.'
The researchers were looking at a group of plant-based products that included soybean and canola oil. How does that factor in with the trend of social influencers trashing seed-based oils?
'I haven't seen anything in the scientific literature that suggests we should be concerned about these seed-based oils,' St-Onge said.
Lichtenstein concurred. 'The data don't show these oils are detrimental,' she said. 'What the data show is that a diet that is high in seed oil and low in animal fats is associated with better health outcomes.'
This article was originally published on NBCNews.com

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hawai'i's CPR training campaign launched by Heart Association
Hawai'i's CPR training campaign launched by Heart Association

Yahoo

time17 hours ago

  • Yahoo

Hawai'i's CPR training campaign launched by Heart Association

HONOLULU (KHON2) — The American Heart Association Hawai'i is rolling out its first-ever Community Impact Days this week, aiming to empower residents with life-saving CPR skills during CPR and AED Awareness Week, observed from June 1 to 7. Spectra Fest bringing the community together AHA Hawai'i's Community Impact Director Elizabeth Cotterell, alongside Dory Clisham, training manager at American Medical Response, spoke about the initiative with Chris Latronic live from the AHA headquarters on Richards Street. The campaign focuses on Hands-Only CPR training, particularly important as children head into summer and spend more time away from trained adults like teachers and coaches. The push comes with a sobering statistic: more than 350,000 people suffer cardiac arrest outside of a hospital each year in the U.S., and about 70% of those incidents occur at home. Without immediate intervention, 90% of these cases are fatal.'CPR can double or even triple someone's chance of survival,' Cotterell said. 'And kids as young as 9 years old can learn it.' As part of its centennial year, the American Heart Association is calling on every family in Hawai'i to help build a 'Nation of Lifesavers'—a movement to ensure that anyone, anywhere is ready to respond during a cardiac emergency. The organization has set an ambitious goal: double the survival rate for cardiac arrest by 2030. Free Hands-Only CPR training sessions will be held this Saturday, June 7, at the Waimānalo Health Center, open to all members of the community. Download the free KHON2 app for iOS or Android to stay informed on the latest news For more information or to register, visit: Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

U.S. Seniors Nearly Double Cannabis Use In Just Two Years, Study Finds
U.S. Seniors Nearly Double Cannabis Use In Just Two Years, Study Finds

Forbes

timea day ago

  • Forbes

U.S. Seniors Nearly Double Cannabis Use In Just Two Years, Study Finds

U.S. Seniors are turning to cannabis more than ever, with use nearly doubling in the past two years, a new study shows. Published this week in JAMA Internal Medicine, four researchers from the University of California and NYU Langone Health found that monthly cannabis use among adults aged 65 and older increased from 4.8% in 2021 to 7% in 2023, resulting in a 45.83% increase. The reasons for this increase are attributed to several factors, including greater access to cannabis. As of today, medical cannabis is legal in 39 states and Washington D.C., while 24 states have also legalized it for recreational use. The situation was slightly different in 2021, when medical cannabis was legal in 36 states and recreational use was legal in 17 states. In 2021, New York, Virginia, New Mexico, and Connecticut legalized cannabis for recreational use. The rise in access to cannabis, both medical and recreational, helps explain why more older adults are using it, especially as more people become aware of medical programs and the health issues cannabis can help treat. This cross-sectional study analyzed 15,689 adults aged 65 and older using data from the National Survey on Drug Use and Health (NSDUH), a nationwide survey of people in the U.S. who aren't living in institutions. The findings show that, between 2021 and 2023, cannabis use among older adults in the U.S. saw a significant rise, with some groups showing especially sharp increases. People with a college or postgraduate degree, for example, went from 4.9% to 8.3% in cannabis use. Among those earning $75,000 or more, cannabis use more than doubled, from 4.2% to 9.1%. Married adults also showed a big jump, going from 3.8% to 7.4%. Older adults living in states where medical cannabis is legal were more likely to use it, and that number kept climbing from 5.4% to 7.9%. 'It shouldn't be surprising that use is becoming increasingly more common among people who live in states that allow medical cannabis, which could be due to increased availability or social acceptability,' said Joseph Palamar, the study's senior author in a press statement, adding that 'with respect to income, those with the highest incomes had the lowest prevalence of cannabis use in 2021, but by 2023 this group had the highest prevalence, which may indicate who has access to medical cannabis given its costs.' The most dramatic increase came from people with chronic obstructive pulmonary disease (COPD), whose usage doubled from 6.4% to 13.5%. People with chronic conditions like cancer, diabetes, heart disease, and high blood pressure also reported using cannabis more. And those dealing with two or more chronic illnesses saw use rise from 3.5% to 8.2%. The authors of this study concluded that these findings show a real shift in how older adults are using cannabis, especially those living with chronic illnesses, and that people with multiple health conditions were more likely to use it. However, they also highlighted that 'the use of cannabis products, especially with psychoactive properties, may complicate chronic disease management among older adults.' These new findings line up with what earlier studies have shown. Back in 2020, a study published in the same journal looked at data from nearly 15,000 adults over 65 using the same national survey and found that cannabis use among older adults had already been on the rise for years, jumping from just 0.4% in 2006 and 2007 to 2.9% by 2015 and 2016. In recent years, researchers have also started to study how long-term cannabis use affects older adults. For example, a study published last year suggested that taking low doses of THC over time may not only help protect the brain from aging but also boost memory, improve cognitive function, and support seniors's overall well-being and longevity. This likely has to do with a key cellular pathway called mTOR, which is a protein that helps control how cells use energy and build new connections in the brain, which are important for learning and memory.

MedTech Innovator Unveils 65 Breakthrough Medtech Startups in its 2025 Cohort
MedTech Innovator Unveils 65 Breakthrough Medtech Startups in its 2025 Cohort

Yahoo

timea day ago

  • Yahoo

MedTech Innovator Unveils 65 Breakthrough Medtech Startups in its 2025 Cohort

—Top 4% of Global Applicants Selected to Compete for $800K in Non-Dilutive Funding and Unmatched Industry Access— —Up to 13 Companies to Participate in American Heart Association and American Society of Plastic Surgeons Specialty Accelerator Tracks— LOS ANGELES, June 05, 2025--(BUSINESS WIRE)--MedTech Innovator (MTI), the world's largest and most impactful accelerator for medical technology startups, today announced the 65 companies selected for its highly competitive 2025 Accelerator Cohort. These companies, representing the top four percent of nearly 1,500 global applicants, will participate in MTI's flagship four-month program designed to de-risk innovation and accelerate the path to U.S. market success. The 2025 cohort includes early and mid-stage medical device, diagnostic, and digital health companies that will receive unparalleled mentorship, strategic guidance, and access to MTI's world-class ecosystem of industry-leading strategic manufacturers, investors, providers, payers, patients, and other industry stakeholders. Participants also join the highest-performing peer network in the sector. MTI alumni have collectively brought over 400 products to market and raised $10 billion in follow-on funding. Companies in this year's cohort will compete for a share of $800,000 in non-dilutive funding, with winners selected by audience vote at major industry conferences. "MedTech Innovator's accelerator is a comprehensive platform for risk mitigation and value creation that helps the world's most promising medtech startups become investable," said Paul Grand, CEO and founder. "Over the next four months, our 2025 cohort will work closely with MTI's extensive network of mentors and partners to advance these innovative technologies toward U.S. market access and public health benefit." Following a rigorous evaluation process, MTI and its corporate partners invited 213 companies (15 percent of applicants) to pitch at this year's MedTech Innovator Road Tour events in Los Angeles, College Park, Md., and Dublin. The 65 selected cohort companies received feedback from 430 subject matter experts and represent 17 U.S. states and 13 countries. The MedTech Innovator 2025 Cohort includes: Cardiovascular & Interventional Adaptyx Biosciences - Menlo Park, Calif. Armor Medical - Atlanta ARTINESS - Milano, Italy CathVision - København NV, Denmark Conform Medical - San Francisco CircuCare - San Diego Emboa Medical - West Lafayette, Ind. Kelvin Health - Sofia, Bulgaria IntelVasc - San Francisco LightHearted AI Health - London MedLumics - Madrid Narwhal Medical - Minneapolis Octin Health - Minneapolis Peerbridge Health - Brentwood, Tenn. Powerful Medical - New York STENTiT - Eindhoven, Netherlands SummaCor - San Diego Toro Neurovascular - Irvine, Calif. VQ Biomedical - Apex, N.C. Diagnostic & Monitoring Crely Healthcare - Oxnard, Calif. EpiWatch - Baltimore Genalyte - San Diego Indigo Diabetes - Gent, Belgium Lumia Health - Boston Luminoah - Charlottesville, Va. Microplate Dx - Glasgow, United Kingdom MiWEndo Solutions - Barcelona, Spain Rivanna Medical - Charlottesville, Va. Sonorous Neurovascular - Lake Forest, Calif. SynchNeuro - Philadelphia Wavelet - New Haven, Conn. Neurology Icometrix - Leuven, Belgium Precisis - Heidelberg, Germany Reach Neuro - Bristol, R.I. Samphire Neuroscience - San Francisco Sinaptica Therapeutics - Cambridge, Mass. Veravas - Austin, Texas Regenerative Medicine & Wound Care Altrazeal Life Sciences - Addison, Texas BioMimir - Sherbrooke, Canada BRIJ Medical - Marietta, Ga. GelSana Therapeutics - Aurora, Colo. inSoma Bio - Durham, N.C. MedCu Technologies - Herzliya, Israel ReGelTec - Baltimore Regenyx Medical - Rehovot, Israel Tempo Therapeutics - San Diego Surgical & Orthopedic Aesclepius Corporation - San Diego Axia Orthopedics - Portland, Ore. Cohesys - Toronto Connected Consumables - Dresden, Germany CytexOrtho - Durham, N.C. HAPPE Spine - Grand Rapids, Mich. Magnendo - Newton, Mass. Magsorbeo Biomedical - Detroit RadioClash - Houston SutureTech - Durham, N.C. Winter Innovations - Knoxville, Tenn. FemTech & Urology Lady Technologies - San Francisco MOMM Diagnostics - Basel, Switzerland Multi4 Medical - Gothenburg, Sweden Multiphze - Glendale, Calif. RenewRX - Denver Starling Medical - Houston Teal Health - San Francisco The Flume Catheter Company - Farnham, United Kingdom This year's program launches at the invitation-only Innovator Summit on June 24-26 in Mountain View, Calif. This event connects the leadership teams from the latest cohorts with MTI's partners, alumni, and other healthcare innovation stakeholders. On June 27, the companies will showcase to investors at MedTech World in San Jose, Calif. The MTI accelerator will culminate with a series of showcases and competitions. All 65 companies will participate October 5-8 in San Diego at The MedTech Conference, powered by AdvaMed, where companies will present in showcase panels and gain access to industry and investor partnering opportunities. The MTI early-stage finals competition will be held at The MedTech Conference on October 6. The MTI mid-stage finals competition will be held November 19-21 at the MedTech Strategist Innovation Summit in San Diego. As part of this year's accelerator, five companies will participate in the MTI/ASPS Plastic Surgery Accelerator track held in partnership with the American Society for Plastic Surgeons (ASPS); and up to eight will participate in the Heart and Brain Health Accelerator in collaboration with the American Heart Association Ventures and Center for Health Technology and Innovation (CHTI). Participants in these specialty tracks will receive additional mentorship from their respective sponsors/collaborators and opportunities to participate in additional industry events. MedTech Innovator's founding sponsors are Johnson & Johnson MedTech and Research Corporation Technologies. Annual program sponsors include Asahi Intecc, Becton Dickinson and Company, Dexcom, Edwards Lifesciences, NIPRO Medical, Olympus Corporation of the Americas, W. L. Gore & Associates, Zimmer Biomet, Andrews Cooper, BioT Medical, Cambridge Consultants, Canon Quality Group, Medmarc, Minnetronix Medical, PDV MedTech, ProLucid Technologies, PRIA Healthcare, Proxima Clinical Research, RegNav, Siemens, Veeva Systems, Velentium, and Veranex. MTI's Association collaborators are the American Heart Association Ventures, the American Heart Association's Center for Health Technology and Innovation (CHTI), and the American Society for Plastic Surgeons (ASPS). The organization's industry partners include AdvaMed, DeviceTalks, Health+Commerce, MedTech Strategist, and Wilson Sonsini. About MedTech Innovator MedTech Innovator is the world's largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 700 graduates. Alumni have collectively raised $10 billion in follow-on funding and introduced 400+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI's website, follow them on LinkedIn, and subscribe to its monthly newsletter. View source version on Contacts Media Contact Jenna KaneHealth+Commercejennakane@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store